Amalgamated Bank’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $111K | Hold |
3,915
| – | – | ﹤0.01% | 1679 |
|
2025
Q1 | $116K | Buy |
3,915
+418
| +12% | +$12.4K | ﹤0.01% | 1645 |
|
2024
Q4 | $102K | Hold |
3,497
| – | – | ﹤0.01% | 1697 |
|
2024
Q3 | $161K | Hold |
3,497
| – | – | ﹤0.01% | 1623 |
|
2024
Q2 | $143K | Buy |
3,497
+982
| +39% | +$40.2K | ﹤0.01% | 1641 |
|
2024
Q1 | $64K | Sell |
2,515
-3,682
| -59% | -$93.7K | ﹤0.01% | 1812 |
|
2023
Q4 | $56K | Sell |
6,197
-709
| -10% | -$6.41K | ﹤0.01% | 2194 |
|
2023
Q3 | $44K | Hold |
6,906
| – | – | ﹤0.01% | 2308 |
|
2023
Q2 | $77K | Hold |
6,906
| – | – | ﹤0.01% | 2152 |
|
2023
Q1 | $106K | Buy |
6,906
+6
| +0.1% | +$92 | ﹤0.01% | 2038 |
|
2022
Q4 | $153K | Buy |
6,900
+285
| +4% | +$6.32K | ﹤0.01% | 1953 |
|
2022
Q3 | $108K | Buy |
6,615
+425
| +7% | +$6.94K | ﹤0.01% | 2116 |
|
2022
Q2 | $90K | Buy |
6,190
+1,381
| +29% | +$20.1K | ﹤0.01% | 2209 |
|
2022
Q1 | $89K | Buy |
+4,809
| New | +$89K | ﹤0.01% | 2241 |
|